Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 0.62
Day High 0.80
Open:0.62
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Prometic Life Sciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its own orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Prometic conference call to present progress report on AGM corporate action plan
PR Newswire - Fri Jun 22, 11:38AM CDT
PR Newswire - PRNW
Fri Jun 22, 11:38AM CDT
LAVAL, QC , June 22, 2018 /PRNewswire/ -  Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic") announced today that it will hold a conference call on Wednesday June 27, 2018 to report on its progress in implementing the updated corporate plan presented during its AGM on Wednesday May 9 th .  
Prometic conference call to present progress report on AGM corporate action plan
PR Newswire - Fri Jun 22, 11:38AM CDT
PR Newswire - CMTX
Fri Jun 22, 11:38AM CDT
Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic") announced today that it will hold a conference call on Wednesday June 27, 2018 to report on its progress in implementing the updated corporate plan presented during its AGM on Wednesday May 9th.
Prometic Presents New Data on NASH Drug Candidate PBI-4547
PR Newswire - Fri Jun 22, 6:00AM CDT
PR Newswire - CMTX
Fri Jun 22, 6:00AM CDT
-- New data suggest PBI-4547 offers potential as novel therapy for liver fibrosis, nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NAFLD), diabetes and obesity
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.45 +64.44% increase
on 06/28/18
Period Open:0.64
Price movement based on the high, low and last over the given period.
1.01 -26.73% decrease
on 07/11/18
+0.10 (+15.63%) increase
since 06/18/18
3-Month 0.45 +64.44% increase
on 06/28/18
Period Open:0.80
Price movement based on the high, low and last over the given period.
1.01 -26.73% decrease
on 07/11/18
-0.06 (-7.50%) decrease
since 04/18/18
52-Week 0.45 +64.44% increase
on 06/28/18
Period Open:1.60
Price movement based on the high, low and last over the given period.
1.80 -58.89% decrease
on 02/01/18
-0.86 (-53.75%) decrease
since 07/18/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement